Solve Therapeutics
Cambridge, United States· Est.
Solve Therapeutics focuses on developing RNA therapeutics for rare genetic diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $120M
About
Solve Therapeutics focuses on developing RNA therapeutics for rare genetic diseases.
Rare DiseaseGenetics & GenomicsRNA Therapeutics
Funding History
1Total raised:$120M
Venture$120M